Updates are available Correction dated 2023-06-09
Click to view Correction: https://doi.org/10.1038/s41586-023-06286-z
-
Authors
Ken, Megan L. https://orcid.org/0000-0001-8336-9935
Roy, Rohit
Geng, Ainan
Ganser, Laura R.
Manghrani, Akanksha
Cullen, Bryan R. https://orcid.org/0000-0002-8638-6850
Schulze-Gahmen, Ursula https://orcid.org/0000-0003-3919-4474
Herschlag, Daniel https://orcid.org/0000-0002-4685-1973
Al-Hashimi, Hashim M. https://orcid.org/0000-0003-0681-1747
- License Information
-
More Information
Article History
Received: 26 September 2022
Accepted: 12 April 2023
First Online: 17 May 2023
Change Date: 9 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-023-06286-z
Competing interests
: H.M.A.-H. is an adviser to and holds an ownership interest in Base4, an RNA-based drug discovery company. D.H. is a consultant for Radial, an RNA-based drug discovery company.
